List of Medidata eConsent Customers
Velizy-Villacoublay, 78140,
France
Since 2010, our global team of researchers has been studying Medidata eConsent customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Medidata eConsent for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Medidata eConsent for Clinical Trial Management include: Pfizer, a United States based Life Sciences organisation with 81000 employees and revenues of $63.63 billion, Boston Scientific Corp, a United States based Life Sciences organisation with 53000 employees and revenues of $16.74 billion, Duke Clinical Research Institute, a United States based Healthcare organisation with 1300 employees and revenues of $173.0 million, Bioforum the Data Masters, a Israel based Professional Services organisation with 200 employees and revenues of $30.0 million and many others.
Contact us if you need a completed and verified list of companies using Medidata eConsent, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Medidata eConsent customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bioforum the Data Masters | Professional Services | 200 | $30M | Israel | Dassault Systemes | Medidata eConsent | Clinical Trial Management | 2024 | n/a |
In 2024 Bioforum the Data Masters expanded an enterprise implementation with Medidata that added Medidata eConsent within a broader Clinical Trial Management adoption across its biometrics CRO services. The year marks an explicit extension of a decade-long relationship, positioning Medidata eConsent as a core component of Bioforum the Data Masters clinical data stack.
The implementation includes Medidata Clinical Data Studio and Medidata eConsent alongside existing Medidata Rave EDC and Medidata Rave RTSM deployments, with Patient Data Surveillance and RBQM platforms applied for AI-driven biometric and data quality capabilities. Functional configuration focuses on electronic informed consent workflows, centralized clinical data capture, automated surveillance alerts, and risk based quality management to support end-to-end data integrity and regulatory compliance.
Operationally the deployment covers Bioforum the Data Masters biometric services that serve clinical trial sponsors worldwide from the companys Israel base, supporting biotech customers across a range of therapeutic areas and building on delivery experience from roughly 60 studies. The implementation narrative emphasizes unified data flow between electronic consent capture and established EDC and RTSM systems, enabling clinical and biometric datasets to be prepared for analysis within a single Medidata ecosystem.
Governance is structured through an expanded enterprise agreement with Medidata that enables broader access to AI powered capabilities and standardizes biometric and clinical data processes across Bioforum the Data Masters service lines. Rollout details prioritize centralized data management, compliance controls for consent capture, and integration of Patient Data Surveillance and RBQM into operational monitoring and study oversight workflows.
Stated outcomes from the agreement include more efficient, high quality data services for Bioforum the Data Masters customers, improved operational efficiency through AI driven monitoring, and seamless high quality data access for sponsor partners as they progress clinical development.
|
 |
Boston Scientific Corp | Life Sciences | 53000 | $16.7B | United States | Dassault Systemes | Medidata eConsent | Clinical Trial Management | 2021 | n/a |
In 2021 Boston Scientific Corp implemented Medidata eConsent as part of its Clinical Trial Management tooling for medical-device clinical trials in the United States, aiming to better inform and educate potential participants and to accelerate rollout timelines. The deployment of Medidata eConsent focused on patient-facing informed consent workflows and centralized electronic consent documentation to standardize participant education across trial sites.
The Medidata eConsent implementation included participant education and comprehension features, electronic signature capture, consent status tracking, version control and audit trail capabilities consistent with Clinical Trial Management workflows. Configuration emphasized multimedia consent content and structured consent forms to support consistent delivery of information to potential participants and to document consent decisions for regulatory review.
Operational coverage targeted clinical-trial patient engagement at U.S. sites and involved clinical operations staff, site coordinators and patient recruitment functions, aligning consent workflows with study operational processes. The solution was positioned to streamline site interactions and to provide a single source of consent records within study execution practices.
Governance focused on centralized consent content management and standardized workflows to accelerate rollout timelines and ensure consistent documentation practices. Medidata reports post-implementation improvements in patient comprehension, compliance and retention following the Medidata eConsent deployment.
|
 |
Duke Clinical Research Institute | Healthcare | 1300 | $173M | United States | Dassault Systemes | Medidata eConsent | Clinical Trial Management | 2016 | n/a |
In 2016 Duke Clinical Research Institute implemented Medidata eConsent within its Clinical Trial Management ecosystem for the ADAPTABLE decentralized trial. The deployment supported enrollment and engagement of over 15,000 patients across the United States, positioning Medidata eConsent as the electronic consent and enrollment layer for the study.
Medidata eConsent was used in combination with a web portal to collect patient reported data, enabling electronic informed consent, remote enrollment workflows, and ongoing patient engagement. Configuration emphasized consent workflows accessible via the web portal to facilitate decentralized trial participation and to capture patient reported outcomes directly into the trial data stream.
Operational scope focused on clinical trial patient engagement and data capture, affecting study coordinators, remote monitoring workflows, and participant communication channels across trial sites in the United States. Governance and study processes were adjusted to support decentralized consent procedures and standardized eConsent instruments, which reduced site burden and supported improved patient compliance and retention as described in Medidata ADAPTABLE case materials.
|
 |
|
Life Sciences | 81000 | $63.6B | United States | Dassault Systemes | Medidata eConsent | Clinical Trial Management | 2011 | n/a |
|
Buyer Intent: Companies Evaluating Medidata eConsent
- Houston Methodist, a United States based Healthcare organization with 27947 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||